Copyright
©The Author(s) 2002.
World J Gastroenterol. Oct 15, 2002; 8(5): 804-807
Published online Oct 15, 2002. doi: 10.3748/wjg.v8.i5.804
Published online Oct 15, 2002. doi: 10.3748/wjg.v8.i5.804
Table 1 The relationship between hTcf-4 mRNA expression and clinicopathological features of the patients
| n | hTcf-4/β-actin | P | |
| AFP | |||
| ≤ 20 μg/L | 16 | 0.71 ± 0.14 | > 0.05 |
| > 20 μg/L | 16 | 0.67 ± 0.12 | |
| Cirrhotic nodules | |||
| < 0.3 cm | 14 | 0.75 ± 0.11 | > 0.05 |
| ≥ 0.3 cm | 18 | 0.67 ± 0.14 | |
| Tumor size | |||
| ≤ 5 cm | 15 | 0.66 ± 0.13 | > 0.05 |
| > 5 cm | 17 | 0.76 ± 0.12 | |
| Capsule | |||
| well capsule | 14 | 0.61 ± 0.10 | < 0.05 |
| poor capsule | 18 | 0.79 ± 0.10 | |
| Metastasis | |||
| Yes | 15 | 0.78 ± 0.12 | < 0.05 |
| No | 17 | 0.66 ± 0.12 |
- Citation: Jiang Y, Zhou XD, Liu YK, Wu X, Huang XW. Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma. World J Gastroenterol 2002; 8(5): 804-807
- URL: https://www.wjgnet.com/1007-9327/full/v8/i5/804.htm
- DOI: https://dx.doi.org/10.3748/wjg.v8.i5.804
